Drug Stocks

Drug Stocks to Buy: New Statin Guidelines Are a Shot in the Arm for These Generics


They account for 264 million prescriptions annually in the U.S. alone, and $35 billion in annual global sales. Now doctors say these drugs could help treat an entirely different ailment, which affects hundreds of millions of people worldwide. That means sales are about to skyrocket.

And just two drug companies will reap the lion's share of the profits...

Drug Stocks a Good Buy Now as Pharma M&A Hits $50 Billion

Doctor with medical health record

Drug maker Shire has announced it will buy ViroPharma for $4.2 billion. This comes on the heels of Amgen's $10.4 billion offer for Onyx Pharmaceuticals in August and Perrigo's acquisition of Elan Corp. in July for $8.6 billion. Those are just a few of the dozens of pharma deals this year that have enriched shareholders. The good news? This is only the beginning.

You, too, can profit from this "feeding frenzy"...

4 Drug Stocks to Buy Now to Capitalize on Emerging Market Growth

Drug bottles

Overall, this sector has healthy global sales of $959 billion and is expected to grow those sales at a rate of 4.5% a year. But in emerging markets, sales in this sector will grow at three times that rate. And on top of that, another development will make these markets even more lucrative.

We've identified the handful of companies best-positioned to take advantage of this...

© 2015 Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201, Email: customerservice@MoneyMorning.com